[Effects of erythromycin on the Pseudomonas-induced rabbit diffuse panbronchiolitis model--the improvements in granuloma-like lesions with increasing production of MCP-1].
Takahashi
T
T
Suga
M
M
Sato
K
K
Okamoto
T
T
Ichiyasu
H
H
Matsukawa
A
A
Okawara
S
S
Yoshinaga
S
S
Ando
M
M
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001988:Bronchiolitis / Q000188:drug therapy* / Q000382:microbiology* / Q000473:pathology; D018932:Chemokine CCL2 / Q000378:metabolism*; D004195:Disease Models, Animal; D004917:Erythromycin / Q000494:pharmacology / Q000627:therapeutic use*; D005487:Foam Cells / Q000473:pathology; D006099:Granuloma / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D008171:Lung Diseases / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D008297:Male; D020556:Neutrophil Infiltration; D011552:Pseudomonas Infections; D011817:Rabbits
D000900:Anti-Bacterial Agents; D018932:Chemokine CCL2; D004917:Erythromycin